Basic Information
LncRNA/CircRNA Name | OIP5-AS1 |
Synonyms | NA |
Region | GRCh38_15:41283990-41309737 |
Ensemble | ENSG00000247556 |
Refseq | NR_026757 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | lung cancer |
ICD-0-3 | C34 |
Methods | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown, RIP |
Sample | lung cancer tissues, cell lines (A549 and H520) |
Expression Pattern | up-regulated |
Function Description | OIP5-AS1 was highly expressed in lung cancer tissues and was correlated with tumor size and tumor growth speed. OIP5-AS1 overexpression increased lung cancer cell proliferation in vitro. Further investigation revealed that OIP5-AS1 functions as a competing endogenous RNA of miR-378a-3p. MiR-378a-3p overexpression inhibited cell proliferation and caused proliferation-associated proteins CDK4 and CDK6 to decrease in A549 cells. Overexpression of wild type OIP5-AS1 led to strong CDK4 and CDK6 expression; however, these two proteins did not change when mutated OIP5-AS1 was upregulated. Finally, in vivo assay showed that the speed of tumor growth was increased and decreased when OIP5-AS1 was upregulated and downregulated, respectively. |
Pubmed ID | 29897167 |
Year | 2018 |
Title | Long Non-Coding RNA OIP5-AS1 Promotes Proliferation of Lung Cancer Cells and Leads to Poor Prognosis by Targeting miR-378a-3p |
External Links
Links for OIP5-AS1 | GenBank HGNC NONCODE |
Links for lung cancer | OMIM COSMIC |